![](/img/cover-not-exists.png)
Reply to: Graefe-Mody U, Friedrich C, Port A et al. Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin. Diabetes Obes Metab 2011; 13: 939–946
B. Snyder, T. M. Polasek, M. P. DoogueVolume:
14
Year:
2012
Language:
english
Pages:
1
DOI:
10.1111/j.1463-1326.2012.01588.x
File:
PDF, 436 KB
english, 2012